Catalyst Pharmaceuticals (CPRX) Assets Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.27% |
| Dec 31, 2025 | 29.66% |
| Sep 30, 2025 | 36.22% |
| Jun 30, 2025 | 37.59% |
| Mar 31, 2025 | 40.55% |
| Dec 31, 2024 | 81.11% |
| Sep 30, 2024 | 86.83% |
| Jun 30, 2024 | 59.13% |
| Mar 31, 2024 | 58.80% |
| Dec 31, 2023 | 25.15% |
| Sep 30, 2023 | 24.04% |
| Jun 30, 2023 | 66.06% |
| Mar 31, 2023 | 64.89% |
| Dec 31, 2022 | 57.97% |
| Sep 30, 2022 | 49.21% |
| Jun 30, 2022 | 27.82% |
| Mar 31, 2022 | 25.23% |
| Dec 31, 2021 | 23.62% |
| Sep 30, 2021 | 27.67% |
| Jun 30, 2021 | 59.14% |
| Mar 31, 2021 | 67.30% |
| Dec 31, 2020 | 71.17% |
| Sep 30, 2020 | 80.84% |
| Jun 30, 2020 | 67.97% |
| Mar 31, 2020 | 93.00% |
| Dec 31, 2019 | 85.90% |
| Sep 30, 2019 | 42.80% |
| Jun 30, 2019 | 5.31% |
| Mar 31, 2019 | -22.81% |
| Dec 31, 2018 | -29.21% |
| Sep 30, 2018 | 95.52% |
| Jun 30, 2018 | 106.47% |
| Mar 31, 2018 | 109.91% |
| Dec 31, 2017 | 104.73% |
| Sep 30, 2017 | -23.57% |
| Jun 30, 2017 | -26.48% |
| Mar 31, 2017 | -29.76% |
| Dec 31, 2016 | -30.61% |
| Sep 30, 2016 | -29.82% |
| Jun 30, 2016 | -28.38% |
| Mar 31, 2016 | -29.43% |
| Dec 31, 2015 | 36.88% |
| Sep 30, 2015 | 40.83% |
| Jun 30, 2015 | 48.79% |
| Mar 31, 2015 | 242.11% |
| Dec 31, 2014 | 73.07% |
| Sep 30, 2014 | 59.76% |
| Jun 30, 2014 | 266.11% |
| Dec 31, 2013 | 51.11% |
| Dec 31, 2012 | 168.66% |
| Dec 31, 2011 | 7.16% |